Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations

被引:83
作者
Bednarczuk, T
Hiromatsu, Y
Fukutani, T
Jazdzewski, K
Miskiewicz, P
Osikowska, M
Nauman, J
机构
[1] Polish Acad Sci, Med Res Ctr, Dept Endocrinol, PL-02097 Warsaw, Poland
[2] Kurume Univ, Sch Med, Dept Endocrinol, Kurume, Fukuoka 830, Japan
[3] Med Univ Warsaw, Dept Endocrinol, PL-02097 Warsaw, Poland
关键词
D O I
10.1530/eje.0.1480013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The development and severity of Graves' ophthalmopathy (GO) may result from a complex interplay of genetic and environmental factors. The aim of this study was to investigate the association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors (age, sex, cigarette smoking) with GO in two different populations, Polish-Caucasians and Japanese. Design: We investigated the distribution of CTLA-4 A49G polymorphism in 264 Caucasian patients with Graves' disease (GD), of which 95 had clinically evident GO (NOSPECS class greater than or equal to 3) and 319 Japanese patients with GD, of which 99 had ophthalmopathy. The control groups consisted of healthy Polish adults (n = 194), Polish centenarians (n = 51) and Japanese adults (n = 112). Results: Allele G and GIG genotype were significantly increased in Caucasian patients with GD (48% and 25% respectively) and in Japanese patients with GD (69% and 47% respectively) compared with control groups. There were no significant differences in the G allele and GIG genotype frequencies in GO patients compared with GD patients without ophthalmopathy. Multiple logistic regression analysis demonstrated that cigarette smoking (P = 0.03, odds ratio (OR) = 1. 7) and age of onset of GD over 42 years (P = 0.08; OR = 1.6) were contributing factors associated with susceptibility to GO in Polish patients. In Japanese patients, a younger age of onset of GD had an effect on the development of GO (P = 0.02, OR = 1.8). Conclusions: (i) Allele G and GIG genotype confer genetic susceptibility to GD; (ii) CTLA-4 A49G polymorphism is not associated with the development of GO; (iii) different non-genetic factors may contribute to GO in different populations.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 34 条
[1]   MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease [J].
Allahabadia, A ;
Heward, JM ;
Nithiyananthan, R ;
Gibson, SM ;
Reuser, TTQ ;
Dodson, PM ;
Franklyn, JA ;
Gough, SCL .
LANCET, 2001, 358 (9286) :984-985
[2]   Genetic markers in diagnosis and prediction of relapse in Graves' disease [J].
Badenhoop, K ;
Donner, H ;
Braun, J ;
Siegmund, T ;
Rau, H ;
Usadel, KH .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :98-100
[3]   MORE ON SMOKING-HABITS AND GRAVES OPHTHALMOPATHY [J].
BARTALENA, L ;
MARTINO, E ;
MARCOCCI, C ;
BOGAZZI, F ;
PANICUCCI, M ;
VELLUZZI, F ;
LOVISELLI, A ;
PINCHERA, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1989, 12 (10) :733-737
[4]   Graves' ophthalmopathy: a preventable disease? [J].
Bartalena, L ;
Marcocci, C ;
Pinchera, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (04) :457-461
[5]   Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Bogazzi, F ;
Manetti, L ;
Tanda, ML ;
Dell'Unto, E ;
Bruno-Bossio, G ;
Nardi, M ;
Bartolomei, MP ;
Lepri, A ;
Rossi, G ;
Martino, E ;
Pinchera, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78
[6]   T-cell-mediated immunity in thyroid-associated ophthalmopathy [J].
Bednarczuk, T ;
Hiromatsu, Y ;
Inoue, Y ;
Yamamoto, K ;
Wall, JR ;
Nauman, J .
THYROID, 2002, 12 (03) :209-215
[7]   Evidence for a major role of heredity in Graves' disease:: A population-based study of two Danish twin cohorts [J].
Brix, TH ;
Kyvik, KO ;
Christensen, K ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :930-934
[8]   GRAVES OPHTHALMOPATHY - CURRENT CONCEPTS REGARDING PATHOGENESIS AND MANAGEMENT [J].
BURCH, HB ;
WARTOFSKY, L .
ENDOCRINE REVIEWS, 1993, 14 (06) :747-793
[9]   CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy [J].
Buzzetti, R ;
Nisticò, L ;
Signore, A ;
Cascino, I .
LANCET, 1999, 354 (9192) :1824-1824
[10]   CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J].
Donner, H ;
Rau, H ;
Walfish, PG ;
Braun, J ;
Siegmund, T ;
Finke, R ;
Herwig, J ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :143-146